{"id":1386,"date":"2025-01-23T16:51:01","date_gmt":"2025-01-23T16:51:01","guid":{"rendered":"https:\/\/fhucare2.laurent-angeli.fr\/event\/hallmarks-of-cd8-t-cell-dysfunction-are-established-within-hours-of-tumor-antigen-encounter-before-cell-division-nat-immunol-tijc4\/"},"modified":"2025-12-25T19:00:48","modified_gmt":"2025-12-25T18:00:48","slug":"hallmarks-of-cd8-t-cell-dysfunction-are-established-within-hours-of-tumor-antigen-encounter-before-cell-division-nat-immunol-tijc4","status":"publish","type":"post","link":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/event\/hallmarks-of-cd8-t-cell-dysfunction-are-established-within-hours-of-tumor-antigen-encounter-before-cell-division-nat-immunol-tijc4\/","title":{"rendered":"Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division (Nat Immunol.) TIJC#4"},"content":{"rendered":"<p><span style=\"color: #495bbc\"><strong><span style=\"font-family: tahoma, arial, helvetica, sans-serif;font-size: 18pt\">WEBINAR Transdisciplinary Immunology Journal Club<\/span><\/strong><\/span><br \/><span style=\"font-family: tahoma, arial, helvetica, sans-serif;font-size: 14pt\"><span style=\"color: #ffff00;background-color: #000000\"><strong>Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division (Nat Immunol.)<\/strong><\/span>&nbsp;&nbsp;<br \/>With Dr&nbsp;Matthieu ROULLEAUX DUGAGE<\/span><br \/><span style=\"font-family: tahoma, arial, helvetica, sans-serif;font-size: 14pt\">Thursday, February 27, 2025 from 5:00 PM to 6:00 PM<\/p>\n<p><\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-family: tahoma, arial, helvetica, sans-serif;background-color: #000000;color: #ffcc00\">Revoir en Replay TIJC#1<br \/><a href=\"https:\/\/youtu.be\/1k7rr2e4HxQ?si=rfk5Vm8aY4OLnY9f&amp;t=1\" style=\"background-color: #000000;color: #ffcc00\"><strong>JAK Inhibitors and Cancer: Friend or Foe?&nbsp;<\/strong>Par le Dr Samuel Bitoun, disponible ICI<\/a><\/span><\/p>\n<\/p>\n<p><span style=\"font-family: tahoma, arial, helvetica, sans-serif;background-color: #000000;color: #ffcc00\">Revoir en Replay TIJC#2 <br \/><strong>The type 2 cytokine Fc\u2013IL-4 revitalizes exhausted CD8+ T cells against cancer, Nature 2024.&nbsp;<\/strong>P<a href=\"https:\/\/youtu.be\/j6wn-f__GwU?si=NzuWOsK-geE3XuRN\" style=\"background-color: #000000;color: #ffcc00\">ar le Dr Fran\u00e7ois-Xavier Danlos, disponible ICI<\/a><\/span><\/p>\n<\/p>\n<p><span style=\"font-family: tahoma, arial, helvetica, sans-serif;background-color: #000000;color: #ffcc00\">Revoir en Replay TIJC#3<br \/><strong>Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis, JExpMed.&nbsp;<br \/><\/strong>With Dr Marie ROBERT.<strong>&nbsp;REPLAY HERE !&nbsp;<\/strong><\/span><\/p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>WEBINAR Transdisciplinary Immunology Journal ClubHallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division (Nat Immunol.)&nbsp;&nbsp;With Dr&nbsp;Matthieu ROULLEAUX DUGAGEThursday, February 27, 2025 from 5:00 PM to 6:00 PM &nbsp; Revoir en Replay TIJC#1JAK Inhibitors and Cancer: Friend or Foe?&nbsp;Par le Dr Samuel Bitoun, disponible ICI Revoir en Replay [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1387,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"event_date":"Friday February 27th 2025","event_location":"online webinar","event_time":"5:00 PM \u2013 6:00 PM","footnotes":""},"categories":[10],"tags":[],"class_list":["post-1386","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event"],"_links":{"self":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/comments?post=1386"}],"version-history":[{"count":2,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1386\/revisions"}],"predecessor-version":[{"id":2386,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1386\/revisions\/2386"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media\/1387"}],"wp:attachment":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media?parent=1386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/categories?post=1386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/tags?post=1386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}